School of Medicine
Showing 1-28 of 28 Results
-
Vincent Michael Alford
Postdoctoral Scholar, Stem Cell Biology and Regenerative Medicine
Current Research and Scholarly InterestsMy interest in science and research was fostered at a young age after losing a family member to colorectal cancer. At that young age, it was made apparent to me that cancer remains poorly understood which is reflected in the total lack of target-specific treatment regiments available to this patient population. This disparity in patient care is what inspired me to pursue a Ph.D in Molecular and Cellular Pharmacology at Stony Brook University (SBU). During my time at SBU, my dissertation research focused on the development of a standard approach for rational drug design against the functional activity of individual matrix metalloproteinases (MMPs). Results from this work led to the successful development of the first small molecule inhibitor specifically targeting the hemopexin domain of MMP-9. Additionally, I was also given the opportunity to assist in the development of a cell based High-Throughput Screen assay for the identification of small molecules with activity against cancer cell invasion.
After obtaining my Ph.D, I pursued a postdoctoral scholar position at Stanford University within the Institute of Stem Cell Biology and Regenerative Medicine. Currently, my projects have slowly become broader and more focused around protein chemistry. More specifically, my research interest lies in identifying protein targets or cell populations responsible for chronic illnesses such as Triple Negative Breast Cancer and Alzheimer’s disease. After identifying the target, my passion lies in understanding the biological function of said target in various biological signaling cascades and cell niche population maintenance. Another area I specialize in is assigning function to the various domains of individual proteins and prioritizing drug development against the most promising targets. Upon identification of the target and validation of the domains responsible for protein activity- it becomes my mission to develop specific inhibitors against them. To this end, I use techniques such as protein mutagenesis, expression, and purification systems in addition to x-ray crystallography and chemical-protein structure activity relationships to understand, rationally design, and optimize these small molecule inhibitors for potential use in clinical trials. -
Chiara Anselmi
Postdoctoral Scholar, Stem Cell Biology and Regenerative Medicine
BioMy expertise is in the areas of regeneration, evolution, the nervous system and cell biology. I use a marine colonial tunicate, Botryllus schlosseri, characterized by having robust regenerative capabilities and an assayable and frequent (weekly) CNS (Central nervous system) tissue regeneration and loss throughout adult life. I believe that comparative studies on a simple chordate can help us elucidate the principal mechanisms that are the foundation of regeneration and aging.
I use a multidisciplinary methodology that integrates advanced single cell RNAseq, imaging, multi-parameter flow cytometric isolation of cellular populations and transplantation assays to elucidate the cellular and genetic changes associated with neuronal degeneration process in young and old colonies. -
Jane Antony
Postdoctoral Scholar, Stem Cell Biology and Regenerative Medicine
Current Research and Scholarly InterestsAlthough varying degrees of progress has been made to treat the heterogenous subtypes of breast cancers, metastasis and recurrence remains a major cause of breast cancer-related deaths. My research focuses on drivers of tumor growth and testing new targets for these breast cancers to prevent metastasis and recurrence; specifically, profiling and validating genes enriched in the self-renewing tumorigenic compartment.
-
Joydeep Bhadury
Postdoctoral Scholar, Stem Cell Biology and Regenerative Medicine
Current Research and Scholarly InterestsMy long-term goal is to generate whole human organs in large research animals, which will be universally immune compatible and ready for human transplantation.
-
Sabra Djomehri
Postdoctoral Scholar, Stem Cell Biology and Regenerative Medicine
Current Research and Scholarly InterestsMy passion is translating bioinformatics integrative workflows and engineering platforms from multi-omics data to better discovery of new therapies. Experienced in statistical analyses and mathematical modeling early in my career and currently working on single-cell sequencing analyses (scRNA-seq), genomics (WES), and epigenomics (targeted chromatin ligation), data integration methods, and algorithm development.
-
Jitendra Gurjar
Postdoctoral Scholar, Stem Cell Biology and Regenerative Medicine
BioDr. Gurjar is currently developing a small molecule inhibitor for the treatment of triple negative breast cancer at Stanford ChEM-H Medicinal Chemistry Knowledge Center with Drs. Mark Smith and Michal Clarke. Prior to joining Stanford, he obtained his PhD in Chemistry from the lab of Prof. Valery Fokin, founder of copper-catalyzed azide-alkyne (CuAAC) click chemistry, at the University of Southern California. His research focused on developing new click reactions and their applications spanning across small molecule inhibitors to materials chemistry.
-
Zhen Qi
Postdoctoral Scholar, Stem Cell Biology and Regenerative Medicine
Current Research and Scholarly InterestsMy research focuses on understanding the mechanisms of breast cancer initiation and progression.
-
Christian Thome
Postdoctoral Scholar, Stem Cell Biology and Regenerative Medicine
Current Research and Scholarly Interests- Synaptic integration & neuronal excitability
- Structure-function relationships in neurons
- Circuit engineering for brain-machine interfaces -
Takeshi Uenaka
Postdoctoral Scholar, Stem Cell Biology and Regenerative Medicine
Current Research and Scholarly InterestsNeurodegenerative disease
